MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AdaptHealth Corp. Market Cap 2011-2026 | AHCO
As of April 11, 2026 AdaptHealth Corp. has a market cap of $ 1.64 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap AdaptHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 B | 1.43 B | 1.36 B | 2.13 B | 2.39 B | 2.01 B | 941 M | 310 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.39 B | 310 M | 1.47 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
13.9 B | $ 173.14 | -0.8 % | $ 13 B |  USA |
 |
Bio-Rad Laboratories
BIO
|
7.81 B | $ 279.25 | 0.63 % | $ 7.88 B | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 10.9 | -1.54 % | $ 1.64 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.61 | 0.84 % | $ 38 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.3 | -1.79 % | $ 124 M |  France |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 37.59 | -1.03 % | $ 5.6 K | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 61.79 | 0.83 % | $ 91.5 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.89 | - | $ 1.15 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.0 | -3.86 % | $ 16.9 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 8.68 | -3.12 % | $ 246 M | USA |
 |
Electromed
ELMD
|
175 M | $ 24.12 | -1.19 % | $ 204 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.97 | 0.19 % | $ 375 M | USA |
 |
Inogen
INGN
|
160 M | $ 6.33 | -4.95 % | $ 168 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 62.78 | -0.93 % | $ 3.42 B |  Britain |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.7 | 4.4 % | $ 68.2 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
12.5 B | $ 90.42 | -1.07 % | $ 12.2 B | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.11 | -0.96 % | $ 870 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.04 | 1.62 % | $ 360 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.69 | -1.43 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 54.02 | -4.71 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 36.74 | -0.51 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 85.11 | -1.8 % | $ 2.96 B | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.68 | 0.38 % | $ 122 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 77.87 | -1.62 % | $ 45.5 B | USA |